The DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Recent developments in the use of nanoparticles for treatment of biofilms
Open accessAbstract
Chronic infections have posed a tremendous burden on health care systems worldwide. Approximately 60% of chronic infections are estimated to be related to biofilms, in large part due to the extraordinary antibiotic resistance of biofilm bacteria. Nanoparticle (NP)-based therapies are viable approaches to treat biofilm-associated infections due to NPs’ unique chemical and physical properties, granted by their high surface area to volume ratio. The mechanism underlying the anti-biofilm activity of various types of NPs is actively under investigation. Simply comparing biofilm disruption or reduction rates is not adequate to describe the effectiveness of NPs; many other factors need to be taken into account, such as the NP type, bacterial strain, concentration of NPs, quantification methods, and the biofilm culture environment. This review focuses on recent research on the creation, characterization, and evaluation of NPs for the prevention or treatment of biofilm infections.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“The bactericidal property of TiO 2 NPs depends on their size, stability, and concentration added to the growth medium, which provides greater retention time for bacterium NP interaction, allowing them to interact closely with microbial membranes [23,24].”
From Antibacterial Activity of TiO2 Nanoparticles Prepared by One-Step Laser Ablation in Liquid (2021) · cites this paper as [24]
Experimental — accuracy not yet measuredIn the citing paper
“Nanoparticles can prevent, disrupt and inhibit or disperse bacteria from biofilm infections 30 (Fig. 4c).”
From Nanotechnology approaches for global infectious diseases (2021) · cites this paper as [30]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bacterial Biofilms: A Common Cause of Persistent Infections
Costerton, J. W., Stewart, P. S., & Greenberg, E. P. (1999) · Science · doi:10.1126/science.284.5418.1318 · Cited by 12,167 · cited 2×
“This difference in antibiotic tolerance explains why patients with biofilm infections tend to suffer from chronic complications [1, 2, 13].”
BackgroundFlemming, H.-C., & Wingender, J. (2010) · Nature Reviews Microbiology · doi:10.1038/nrmicro2415 · Cited by 10,137
Magnetic Nanoparticles: Synthesis, Protection, Functionalization, and Application
Lu, A., Salabas, E. L., & Schüth, F. (2007) · Angewandte Chemie International Edition · doi:10.1002/anie.200602866 · Cited by 6,777
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
Gupta, A. K., & Gupta, M. (2005) · Biomaterials · doi:10.1016/j.biomaterials.2004.10.012 · Cited by 6,771
Sondi, I., & Salopek-Sondi, B. (2004) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2004.02.012 · Cited by 5,986
Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide.
Ignarro, L. J., Buga, G. M., Wood, K. S., Byrns, R. E., & Chaudhuri, G. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.24.9265 · Cited by 5,074
Antimicrobial effects of silver nanoparticles
Kim, J. S., Kuk, E., Yu, K. N., Kim, J.-H., Park, S. J., Lee, H. J., Kim, S. H., Park, Y. K., Park, Y. H., Hwang, C.-Y., et al. (2007) · Nanomedicine: Nanotechnology, Biology and Medicine · doi:10.1016/j.nano.2006.12.001 · Cited by 4,918
Doxil® — The first FDA-approved nano-drug: Lessons learned
Barenholz, Y. (. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.03.020 · Cited by 4,792 · cited 1×
“Since the success of the first liposomal pharmaceutical product, Doxil®, approved by the Food and Drug Administration (FDA) in 1995 [19], NPs have been studied extensively as carriers for drug delivery, imaging contrast agents for diagnosis, and pharmaceutical agents for therapy.”
BackgroundDrug delivery and nanoparticles: Applications and hazards
de Jong (2008) · International Journal of Nanomedicine · doi:10.2147/ijn.s596 · Cited by 3,848
The Involvement of Cell-to-Cell Signals in the Development of a Bacterial Biofilm
Davies, D. G., Parsek, M. R., Pearson, J. P., Iglewski, B. H., Costerton, J. W., & Greenberg, E. P. (1998) · Science · doi:10.1126/science.280.5361.295 · Cited by 3,396
Research works printed but not linked: 149
- 2007, Assessment and interpretation of bacterial viability by using the LIVE/DEAD BacLight Kit in combination with flow cytometry, Appl. Environ. Microbiol., 73, 3283, 10.1128/AEM.02750-06 · DOI · Paper page
- 2011, Biofilm on artificial pacemaker: fiction or reality?, Arq. Bras. Cardiol., 97, e113
- 2014, Externally controlled triggered-release of drug from PLGA micro and nanoparticles, PLoS One, 9, e114271, 10.1371/journal.pone.0114271 · DOI
- 1987, Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide, Proc. Natl. Acad. Sci. USA., 84, 9265, 10.1073/pnas.84.24.9265 · DOI · Paper page
- 2006, Green fluorescent protein-expressing Escherichia coli as a model system for investigating the antimicrobial activities of silver nanoparticles, Langmuir, 22, 9322, 10.1021/la060661v · DOI · Paper page
- 2012, Toxicity and antibacterial assessment of chitosan-coated silver nanoparticles on human pathogens and macrophage cells, Int. J. Nanomedicine, 7, 1805
- 2014, Rapid efficient synthesis and characterization of silver, gold, and bimetallic nanoparticles from the medicinal plant Plumbago zeylanica and their application in biofilm control, Int. J. Nanomedicine, 9, 2635
- 2015, Cerium oxide and iron oxide nanoparticles abolish the antibacterial activity of ciprofloxacin against gram positive and gram negative biofilm bacteria, Cytotechnology, 67, 427, 10.1007/s10616-014-9701-8 · DOI
- 2006, Antimicrobial properties of copper plasma-modified polyethylene, Polymer, 47, 7441, 10.1016/j.polymer.2006.08.057 · DOI
- 2012, Nanomaterials for targeted detection and photothermal killing of bacteria, Chem. Soc. Rev., 41, 3193, 10.1039/c2cs15340h · DOI · Paper page
- 2014, Antibiofilm properties of chemically synthesized silver nanoparticles found against Pseudomonas aeruginosa, J. Nanobiotechnology, 12, 2, 10.1186/1477-3155-12-2 · DOI · Paper page
- 2014, Antibacterial efficacy of iron-oxide nanoparticles against biofilms on different biomaterial surfaces, Int. J. Biomater., 2014, 716080
- 2014, Antibiotic resistance in Pseudomonas aeruginosa biofilms: towards the development of novel anti-biofilm therapies, J. Biotechnol., 191, 121, 10.1016/j.jbiotec.2014.09.003 · DOI · Paper page
- 2011, Influence of copper ions on the viability and cytotoxicity of Pseudomonas aeruginosa under conditions relevant to drinking water environments, Int. J. Hyg. Environ. Health, 214, 485, 10.1016/j.ijheh.2011.06.004 · DOI
- 2016, Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa, Curr. Microbiol., 73, 747, 10.1007/s00284-016-1101-1 · DOI
- 2015, Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity, J. Mater. Sci. Mater. Med., 26, 1
- 2012, Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm, Int. J. Nanomedicine, 7, 3245
- 2010, Antibiotic resistance of bacterial biofilms, Int. J. Antimicrob. Agents., 35, 322, 10.1016/j.ijantimicag.2009.12.011 · DOI · Paper page
- 2013, Prosthesis infections after orthopedic joint replacement: the possible role of bacterial biofilms, Orthop. Rev., 5, 65
- 2015, Mucosal biofilm detection in chronic otitis media: a study of middle ear biopsies from Greenlandic patients, Eur. Arch. Oto-Rhino-Laryngol. Off. J. Eur. Fed. Oto-Rhino-Laryngol. Soc. EUFOS Affil. Ger. Soc. Oto-Rhino-Laryngol. Head Neck Surg., 272, 1079
- 1994, Biodegradable long-circulating polymeric nanospheres, Science, 263, 1600, 10.1126/science.8128245 · DOI · Paper page
- 2009, Small-molecule inhibitors target Escherichia coli amyloid biogenesis and biofilm formation, Nat. Chem. Biol., 5, 913, 10.1038/nchembio.242 · DOI · Paper page
- 1987, Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses, Arch. Surg. Chic. Ill 1960., 122, 38
- 2013, Can eradication rate of gastric Helicobacter pylori be improved by killing oral Helicobacter pylori?, World J. Gastroenterol., 19, 6645, 10.3748/wjg.v19.i39.6645 · DOI
- 2015, One pot synthesis and anti-biofilm potential of copper nanoparticles (CuNPs) against clinical strains of Pseudomonas aeruginosa, Biofouling, 31, 379, 10.1080/08927014.2015.1048686 · DOI · Paper page
- 1987, Surface biofilm disruption. Enhanced recovery of microorganisms from vascular prostheses, Arch. Surg. Chic. Ill 1960., 122, 38
- 2001, Biofilms and device-associated infections, Emerg. Infect. Dis., 7, 277, 10.3201/eid0702.010226 · DOI · Paper page
- 2016, Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa, Curr. Microbiol., 73, 747, 10.1007/s00284-016-1101-1 · DOI
- 2012, Gentamicin-loaded nanoparticles show improved antimicrobial effects towards Pseudomonas aeruginosa infection, Int. J. Nanomedicine, 7, 4053
- 2014, Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data, Lancet Infect. Dis., 14, 742, 10.1016/S1473-3099(14)70780-7 · DOI · Paper page
- 1998, The pharmacodynamics of aminoglycosides, Clin. Infect. Dis. Off. Publ. Infect. Dis. Soc. Am., 27, 23, 10.1086/514620 · DOI · Paper page
- 2013, Nanotechnology as a therapeutic tool to combat microbial resistance, Adv. Drug Deliv. Rev., 65, 1803, 10.1016/j.addr.2013.07.011 · DOI · Paper page
- 2014, Therapeutic strategies to combat antibiotic resistance, Adv. Drug Deliv. Rev., 78, 14, 10.1016/j.addr.2014.10.027 · DOI · Paper page
- 2013, Drug resistance profile and biofilm forming potential of Pseudomonas aeruginosa isolated from contact lenses in Karachi-Pakistan, BMC Ophthalmol., 13, 57, 10.1186/1471-2415-13-57 · DOI
- 1992, Sensitization of oral bacteria to killing by low-power laser radiation, Curr. Microbiol., 25, 77, 10.1007/BF01570963 · DOI · Paper page
- 2012, An investigation on the antibacterial, cytotoxic, and antibiofilm efficacy of starch-stabilized silver nanoparticles, Nanomed. Nanotechnol. Biol. Med., 8, 916, 10.1016/j.nano.2011.11.007 · DOI · Paper page
- 2015, Overcoming barriers in Pseudomonas aeruginosa lung infections: engineered nanoparticles for local delivery of a cationic antimicrobial peptide, Colloids Surf. B Biointerfaces., 135, 717, 10.1016/j.colsurfb.2015.08.027 · DOI
- 2011, Detection of extended spectrum beta lactamases, ampc beta lactamases and metallobetalactamases in clinical isolates of ceftazidime resistant Pseudomonas Aeruginosa, Braz. J. Microbiol., 42, 1284, 10.1590/S1517-83822011000400006 · DOI
- 2016, Quorum-sensing mechanisms and bacterial response to antibiotics in P. aeruginosa, Curr. Microbiol., 73, 747, 10.1007/s00284-016-1101-1 · DOI
- 2014, Synthesis and surface immobilization of antibacterial hybrid silver-poly(l-lactide) nanoparticles, Nanotechnology., 25, 305102, 10.1088/0957-4484/25/30/305102 · DOI
- 2015, Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro, Int. J. Pharm., 495, 728, 10.1016/j.ijpharm.2015.09.055 · DOI
- 2015, Synthesis and antimicrobial activity of monodisperse copper nanoparticles, Colloids Surf. B Biointerfaces, 128, 17, 10.1016/j.colsurfb.2015.02.009 · DOI · Paper page
- 2009, Pseudomonas aeruginosa extracellular products inhibit staphylococcal growth, and disrupt established biofilms produced by Staphylococcus epidermidis, Microbiol. Read. Engl., 155, 2148, 10.1099/mic.0.028001-0 · DOI · Paper page
- 2002, Biofilms as complex differentiated communities, Annu. Rev. Microbiol., 56, 187, 10.1146/annurev.micro.56.012302.160705 · DOI · Paper page
- 2009, The disruption of bacterial membrane integrity through ROS generation induced by nanohybrids of silver and clay, Biomaterials, 30, 5979, 10.1016/j.biomaterials.2009.07.030 · DOI · Paper page
- 2012, Vascular permeability in cancer and infection as related to macromolecular drug delivery, with emphasis on the EPR effect for tumor-selective drug targeting, Proc. Jpn. Acad. Ser. B., 88, 53, 10.2183/pjab.88.53 · DOI · Paper page
- 2008, Nano/micro technologies for delivering macromolecular therapeutics using poly(d,l-lactide-co-glycolide) and its derivatives, J. Controlled Release, 125, 193, 10.1016/j.jconrel.2007.09.013 · DOI · Paper page
- 1999, Measuring antimicrobial effects on biofilm bacteria: from laboratory to field, Methods Enzymol., 310, 608, 10.1016/S0076-6879(99)10047-8 · DOI
- 2015, Distribution and Inhibition of Liposomes on Staphylococcus aureus and Pseudomonas aeruginosa Biofilm, PLoS One, 10, e0131806, 10.1371/journal.pone.0131806 · DOI
- 2012, Gold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilm, Int. J. Nanomedicine, 7, 3245
- 2014, Enhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteria, Nanoscale Res. Lett., 9, 373, 10.1186/1556-276X-9-373 · DOI · Paper page
- 2004, Silver nanoparticles as antimicrobial agent: a case study on E. coli as amodel for Gram-negative bacteria, J. Colloid Interface Sci., 275, 177, 10.1016/j.jcis.2004.02.012 · DOI · Paper page
- 2000, The manufacturing techniques of various drug loaded biodegradable poly(lactide-co-glycolide) (PLGA) devices, Biomaterials, 21, 2475, 10.1016/S0142-9612(00)00115-0 · DOI · Paper page
- 2008, Drug delivery and nanoparticles: applications and hazards, Int. J. Nanomed., 3, 133
- 2010, The biofilm matrix, Nat. Rev. Microbiol., 8, 623, 10.1038/nrmicro2415 · DOI · Paper page
- 2013, Magnetic nanoparticle targeted hyperthermia of cutaneous Staphylococcus aureus infection, Ann. Biomed. Eng., 41, 598, 10.1007/s10439-012-0698-x · DOI · Paper page
- 2015, Chelating and antibacterial properties of chitosan nanoparticles on dentin, Restor. Dent. Endod., 40, 195, 10.5395/rde.2015.40.3.195 · DOI
- 1994, Role of alginate lyase in cell detachment of Pseudomonas aeruginosa, Appl. Environ. Microbiol., 60, 2355, 10.1128/AEM.60.7.2355-2359.1994 · DOI · Paper page
- 2012, A method for quantitative determination of biofilm viability, J. Funct. Biomater., 3, 418, 10.3390/jfb3020418 · DOI · Paper page
- 2001, How to optimize the drop plate method for enumerating bacteria, J. Microbiol. Methods, 44, 121, 10.1016/S0167-7012(00)00241-4 · DOI · Paper page
- 2010, Aqueous re-dispersibility of spray-dried antibiotic-loaded polycaprolactone nanoparticle aggregates for inhaled anti-biofilm therapy, Powder Technol., 203, 432, 10.1016/j.powtec.2010.06.003 · DOI
- 2011, Antimicrobial effect of chitosan nanoparticles on streptococcus mutans biofilms, Appl. Environ. Microbiol., 77, 3892, 10.1128/AEM.02941-10 · DOI · Paper page
- 2006, Biofilms: implications in bioremediation, Trends Microbiol., 14, 389, 10.1016/j.tim.2006.07.001 · DOI · Paper page
- 2005, The resistance of polyvinylpyrrolidone-iodine-poly(-caprolactone) blends to adherence of Escherichia coli, Biomaterials, 26, 2013, 10.1016/j.biomaterials.2004.06.001 · DOI
- 2013, Transport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilms, PLoS One, 8, e79220, 10.1371/journal.pone.0079220 · DOI
- 2013, Biocidal effect of copper and zinc oxide nanoparticles on human oral microbiome and biofilm formation, Mater. Lett., 97, 67, 10.1016/j.matlet.2013.01.085 · DOI
- 2012, Doxil®–the first FDA-approved nano-drug: lessons learned, J. Control. Release Off. J. Control. Release Soc., 160, 117, 10.1016/j.jconrel.2012.03.020 · DOI · Paper page
- 1998, Biofilm susceptibility to bacteriophage attack: the role of phage-borne polysaccharide depolymerase, Microbiol. Read. Engl., 144, 3039, 10.1099/00221287-144-11-3039 · DOI · Paper page
- 2014, Probing the size limit for nanomedicine penetration into Burkholderia multivorans and Pseudomonas aeruginosa biofilms, J. Controlled Release, 195, 21, 10.1016/j.jconrel.2014.07.061 · DOI
- 1998, The involvement of cell-to-cell signals in the development of a bacterial biofilm, Science, 280, 295, 10.1126/science.280.5361.295 · DOI · Paper page
- 2005, Persister cells and the riddle of biofilm survival, Biochem. Biochemistry (Moscow), 70, 267, 10.1007/s10541-005-0111-6 · DOI · Paper page
- 2011, ‘Persisters’: survival at the cellular level, PLoS Pathog., 7, e1002121, 10.1371/journal.ppat.1002121 · DOI
- 2004, Polyurethane vascular catheter surface grafted with zwitterionic sulfobetaine monomer activated by ozone, Colloids Surf. B Biointerfaces, 35, 1, 10.1016/j.colsurfb.2004.01.005 · DOI
- 2012, Clinical development of liposome-based drugs: formulation, characterization, and therapeutic efficacy, Int. J. Nanomedicine, 7, 49
- 2007, Magnetic nanoparticles: synthesis, protection, functionalization, and application, Angew. Chem. Int. Ed., 46, 1222, 10.1002/anie.200602866 · DOI · Paper page
- 2013, Role of size and shape on biofilm eradication for nitric oxide-releasing silica nanoparticles, ACS Appl. Mater. Interfaces, 5, 9322, 10.1021/am402618w · DOI · Paper page
- 2012, Lipid-polymer hybrid nanoparticles with rhamnolipid-triggered release capabilities as anti-biofilm drug delivery vehicles, Particuology, 10, 327, 10.1016/j.partic.2011.08.007 · DOI
- 2014, Synthesis and evaluation of PEG-O-chitosan nanoparticles for delivery of poor water soluble drugs: ibuprofen, Mater. Sci. Eng. C, 41, 91, 10.1016/j.msec.2014.04.035 · DOI
- 2010, Silver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidis, Colloids Surf. B Biointerfaces, 79, 340, 10.1016/j.colsurfb.2010.04.014 · DOI · Paper page
- 1999, Bacterial biofilms: a common cause of persistent infections, Science., 284, 1318, 10.1126/science.284.5418.1318 · DOI · Paper page
- 2005, An investigation of the thermal inactivation of Staphylococcus aureus and the potential for increased thermotolerance as a result of chilled storage, J. Appl. Microbiol., 99, 1229, 10.1111/j.1365-2672.2005.02697.x · DOI
- 2008, Prevention of hospital-acquired infections: review of non-pharmacological interventions, J. Hosp. Infect., 69, 204, 10.1016/j.jhin.2008.03.018 · DOI · Paper page
- 2008, On the mechanisms of biocompatibility, Biomaterials, 29, 2941, 10.1016/j.biomaterials.2008.04.023 · DOI · Paper page
- 2000, Molecular mechanisms that confer antibacterial drug resistance, Nature., 406, 775, 10.1038/35021219 · DOI · Paper page
- 2012, Surface charge-switching polymeric nanoparticles for bacterial cell wall-targeted delivery of antibiotics, ACS Nano., 6, 4279, 10.1021/nn3008383 · DOI · Paper page
- 2011, Potential antibacterial activity of carvacrol-loaded poly(DL-lactide-co-glycolide) (PLGA) nanoparticles against microbial biofilm, Int. J. Mol. Sci., 12, 5039, 10.3390/ijms12085039 · DOI · Paper page
- 2012, Synthesis and antimicrobial activity of copper nanoparticles, Mater. Lett., 71, 114, 10.1016/j.matlet.2011.12.055 · DOI · Paper page
- 2012, Magnetic targeting of surface-modified superparamagnetic iron oxide nanoparticles yields antibacterial efficacy against biofilms of gentamicin-resistant staphylococci, Acta Biomater., 8, 2047, 10.1016/j.actbio.2012.03.002 · DOI · Paper page
- 2016, Biphasic release of gentamicin from chitosan/fucoidan nanoparticles for pulmonary delivery, Carbohydr. Polym., 138, 114, 10.1016/j.carbpol.2015.11.072 · DOI
- 2014, Nanoparticle-encapsulated chlorhexidine against oral bacterial biofilms, PLoS One, 9, e103234, 10.1371/journal.pone.0103234 · DOI
- 2013, Antibacterial effects of silver nanoparticles on gram-negative bacteria: influence on the growth and biofilms formation, mechanisms of action, Colloids Surf. B Biointerfaces, 102, 300, 10.1016/j.colsurfb.2012.07.039 · DOI · Paper page
- 2015, Strategies for combating bacterial biofilm infections, Int. J. Oral Sci., 7, 1, 10.1038/ijos.2014.65 · DOI · Paper page
- 2014, Ferromagnetic nanoparticles with peroxidase-like activity enhance the cleavage of biological macromolecules for biofilm elimination, Nanoscale, 6, 2588, 10.1039/C3NR05422E · DOI · Paper page
- 2006, Chitosan nanoparticles as a potential drug delivery system for the ocular surface: toxicity, uptake mechanism and in vivo tolerance, Investig. Opthalmology Vis. Sci., 47, 1416, 10.1167/iovs.05-0495 · DOI · Paper page
- 2015, Enhancing the stability and antibiofilm activity of DspB by immobilization on carboxymethyl chitosan nanoparticles, Microbiol. Res., 178, 35, 10.1016/j.micres.2015.06.001 · DOI
- 2007, Removal of heavy metals from aqueous systems with thiol functionalized superparamagnetic nanoparticles, Environ. Sci. Technol., 41, 5114, 10.1021/es0705238 · DOI · Paper page
- 2001, Biofilms and planktonic cells of Pseudomonas aeruginosa have similar resistance to killing by antimicrobials, J. Bacteriol., 183, 6746, 10.1128/JB.183.23.6746-6751.2001 · DOI · Paper page
- 2002, Biodegradable nanoparticles for drug delivery and targeting, Curr. Opin. Solid State Mater. Sci., 6, 319, 10.1016/S1359-0286(02)00117-1 · DOI · Paper page
- 2008, Comparison of multiple methods for quantification of microbial biofilms grown in microtiter plates, J. Microbiol. Methods, 72, 157, 10.1016/j.mimet.2007.11.010 · DOI · Paper page
- 2005, Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications, Biomaterials, 26, 3995, 10.1016/j.biomaterials.2004.10.012 · DOI · Paper page
- 2014, Magnetic hyperthermia with magnetic nanoparticles: a status review, Curr. Top. Med. Chem., 14, 572, 10.2174/1568026614666140118203550 · DOI · Paper page
- 2011, Influence of scaffold size on bactericidal activity of nitric oxide releasing silica nanoparticles, ACS Nano, 5, 7235, 10.1021/nn202054f · DOI
- 2009, Characterisation of copper oxide nanoparticles for antimicrobial applications, Int. J. Antimicrob. Agents, 33, 587, 10.1016/j.ijantimicag.2008.12.004 · DOI · Paper page
- 2011, The roles of lipid in anti-biofilm efficacy of lipid–polymer hybrid nanoparticles encapsulating antibiotics, Colloids Surf. Physicochem. Eng. Asp., 389, 158, 10.1016/j.colsurfa.2011.08.035 · DOI
- 2014, Effect of copper salts and reducing agents on characteristics and antimicrobial activity of copper nanoparticles, Mater. Lett., 132, 307, 10.1016/j.matlet.2014.06.014 · DOI
- 2012, Antibacterial properties of nanoparticles, Trends Biotechnol., 30, 499, 10.1016/j.tibtech.2012.06.004 · DOI · Paper page
- 2013, Validation of drop plate technique for bacterial enumeration by parametric and nonparametric tests, Vet. Res. Forum, 4, 179
- 2000, Role of antibiotic penetration limitation in Klebsiella pneumoniae biofilm resistance to ampicillin and ciprofloxacin, Antimicrob. Agents Chemother., 44, 1818, 10.1128/AAC.44.7.1818-1824.2000 · DOI · Paper page
- 2012, An organoselenium compound inhibits Staphylococcus aureus biofilms on hemodialysis catheters in vivo, Antimicrob. Agents Chemother., 56, 972, 10.1128/AAC.05680-11 · DOI
- 2015, Metal-based antibacterial substrates for biomedical applications, Biomacromolecules, 16, 1873, 10.1021/acs.biomac.5b00773 · DOI · Paper page
- 2009, Anti-biofilm efficacy of nitric oxide-releasing silica nanoparticles, Biomaterials, 30, 2782, 10.1016/j.biomaterials.2009.01.052 · DOI · Paper page
- 2011, Synthesis and application of a bromomethyl substituted scaffold to be used for efficient optimization of anti-virulence activity, Eur. J. Med. Chem., 46, 1103, 10.1016/j.ejmech.2011.01.025 · DOI
- 2013, Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era, Cold Spring Harb. Perspect. Med., 3, a010306
- 1981, Preparation of aqueous magnetic liquids in alkaline and acidic media, IEEE Trans. Magn., 17, 1247, 10.1109/TMAG.1981.1061188 · DOI · Paper page
- 2015, Study on inhibitory activity of chitosan-based materials against biofilm producing Pseudomonas aeruginosa strains, J. Biomater. Appl., 30, 269, 10.1177/0885328215578781 · DOI
- 2003, A 6 x 6 drop plate method for simultaneous colony counting and MPN enumeration of Campylobacter jejuni, Listeria monocytogenes, and Escherichia coli, J. Microbiol. Methods, 55, 475, 10.1016/S0167-7012(03)00194-5 · DOI · Paper page
- 2015, Dual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicity, J. Mater. Sci. Mater. Med., 26, 1
- 2015, Current development of silver nanoparticle preparation, investigation, and application in the field of medicine, current development of silver nanoparticle preparation, investigation, and application in the field of medicine, J. Nanomater. J. Nanomater., 2015, e696918, 10.1155/2015/696918 · DOI · Paper page
- 2008, Biofilm penetration, triggered release and in vivo activity of inhaled liposomal amikacin in chronic Pseudomonas aeruginosa lung infections, J. Antimicrob. Chemother., 61, 859, 10.1093/jac/dkn059 · DOI · Paper page
- 2000, Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms, Nature, 407, 762, 10.1038/35037627 · DOI · Paper page
- 2014, Iron oxide nanoparticles induce Pseudomonas aeruginosa growth, induce biofilm formation, and inhibit antimicrobial peptide function, Environ. Sci. Nano, 1, 123, 10.1039/c3en00029j · DOI
- 2010, Polyethyleneimine nanoparticles incorporated into resin composite cause cell death and trigger biofilm stress in vivo, Proc. Natl. Acad. Sci. USA., 107, 22038, 10.1073/pnas.1010341107 · DOI · Paper page
- 2012, Characterization, antibiofilm, and mechanism of action of novel PEG-stabilized lipid nanoparticles loaded with terpinen-4-ol, J. Agric. Food Chem., 60, 6150, 10.1021/jf3010405 · DOI
- 2015, Iron oxide nanoparticle-mediated hyperthermia stimulates dispersal in bacterial biofilms and enhances antibiotic efficacy, Sci. Rep., 5, 18385, 10.1038/srep18385 · DOI
- 2011, Biofilm on artificial pacemaker: fiction or reality?, Arq. Bras. Cardiol., 97, e113
- 2014, Photoactivated rose bengal functionalized chitosan nanoparticles produce antibacterial/biofilm activity and stabilize dentin-collagen, Nanomedicine Nanotechnol. Biol. Med., 10, 491, 10.1016/j.nano.2013.10.010 · DOI · Paper page
- 2010, Structure-based drug design and optimization of mannoside bacterial FimH antagonists, J. Med. Chem., 53, 4779, 10.1021/jm100438s · DOI · Paper page
- 2003, Antimicrobial resistance of Pseudomonas aeruginosa biofilms, Microbes Infect., 5, 1213, 10.1016/j.micinf.2003.08.009 · DOI · Paper page
- 2003, Chitosan as antimicrobial agent: applications and mode of action, Biomacromolecules, 4, 1457, 10.1021/bm034130m · DOI · Paper page
- 2007, Synthesis of nitric oxide-releasing silica nanoparticles, J. Am. Chem. Soc., 129, 4612, 10.1021/ja0674338 · DOI · Paper page
- 2001, Riddle of biofilm resistance, Antimicrob. Agents Chemother., 45, 999, 10.1128/AAC.45.4.999-1007.2001 · DOI · Paper page
- 2003, Contributions of antibiotic penetration, oxygen limitation, and low metabolic activity to tolerance of Pseudomonas aeruginosa biofilms to ciprofloxacin and tobramycin, Antimicrob. Agents Chemother., 47, 317, 10.1128/AAC.47.1.317-323.2003 · DOI · Paper page
- 2005, Introduction: antibiotic resistance, Chem. Rev., 105, 391, 10.1021/cr030100y · DOI · Paper page
- 2002, Mechanisms of antibiotic resistance in bacterial biofilms, Int. J. Med. Microbiol., 292, 107, 10.1078/1438-4221-00196 · DOI · Paper page
- 2011, Synthesis and characterization of chitosan and silver loaded chitosan nanoparticles for bioactive polyester, Carbohydr. Polym., 83, 438, 10.1016/j.carbpol.2010.08.004 · DOI · Paper page
- 2010, Antibiotic resistance and its cost: is it possible to reverse resistance?, Nat. Rev. Microbiol., 8, 260, 10.1038/nrmicro2319 · DOI · Paper page
- 2005, Sociomicrobiology: the connections between quorum sensing and biofilms, Trends Microbiol., 13, 27, 10.1016/j.tim.2004.11.007 · DOI · Paper page
- 2014, Synergy of silver nanoparticles and aztreonam against Pseudomonas aeruginosa PAO1 biofilms, Antimicrob. Agents Chemother., 58, 5818, 10.1128/AAC.03170-14 · DOI
- 1983, Comparison between multilamellar and unilamellar liposomes in enhancing antibody formation, Immunology, 49, 37
- 2012, Superparamagnetic iron oxide nanoparticles (SPION) for the treatment of antibiotic-resistant biofilms, Small, 8, 3016, 10.1002/smll.201200575 · DOI
- 2015, Disassembling bacterial extracellular matrix with DNase-coated nanoparticles to enhance antibiotic delivery in biofilm infections, J. Controlled Release, 209, 150, 10.1016/j.jconrel.2015.04.028 · DOI · Paper page
- 2013, Enhanced efficacy of superparamagnetic iron oxide nanoparticles against antibiotic-resistant biofilms in the presence of metabolites, Adv. Mater., 25, 5706, 10.1002/adma.201302627 · DOI
- 2011, Polylactide-co-glycolide nanoparticles for controlled delivery of anticancer agents, Int. J. Nanomedicine, 6, 877
- 2004, Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa, Antimicrob. Agents Chemother., 48, 1320, 10.1128/AAC.48.4.1320-1328.2004 · DOI · Paper page
- 2007, Antimicrobial effects of silver nanoparticles, Nanomedicine, 3, 95, 10.1016/j.nano.2006.12.001 · DOI · Paper page
- 2009, The growing importance of materials that prevent microbial adhesion: antimicrobial effect of medical devices containing silver, Int. J. Antimicrob. Agents, 34, 103, 10.1016/j.ijantimicag.2009.01.017 · DOI · Paper page
- 2010, Pseudomonas aeruginosa biofilms in cystic fibrosis, Future Microbiol., 5, 1663, 10.2217/fmb.10.125 · DOI · Paper page
- 2016, Potent antimicrobial and antibiofilm activities of bacteriogenically synthesized gold-silver nanoparticles against pathogenic bacteria and their physiochemical characterizations, J. Biomater. Appl., 31, 366, 10.1177/0885328216646910 · DOI
- 2012, Chitosan nanoparticles for antimicrobial photodynamic inactivation: characterization and in vitro investigation, Photochem. Photobiol., 88, 570, 10.1111/j.1751-1097.2012.01101.x · DOI
Cited by
Nanotechnology approaches for global infectious diseases
Kirtane, A. R., Verma, M., Karandikar, P., Furin, J., Langer, R., & Traverso, G. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-00866-8 · Cited by 520
Metal Oxide Nanoparticles Against Bacterial Biofilms: Perspectives and Limitations
Shkodenko, L., Kassirov, I., & Koshel, E. (2020) · Microorganisms · doi:10.3390/microorganisms8101545 · Cited by 296
The effect of nano-SiO2 on concrete properties: a review
Zhuang, C., & Chen, Y. (2019) · Nanotechnology Reviews · doi:10.1515/ntrev-2019-0050 · Cited by 193
Antibacterial Activity of TiO2 Nanoparticles Prepared by One-Step Laser Ablation in Liquid
Khashan, K. S., Sulaiman, G. M., Abdulameer, F. A., Albukhaty, S., Ibrahem, M. A., Al-Muhimeed, T., & AlObaid, A. A. (2021) · Applied Sciences · doi:10.3390/app11104623 · Cited by 182
Polymicrobial Infections and Biofilms: Clinical Significance and Eradication Strategies
Anju, V. T., Busi, S., Imchen, M., Kumavath, R., Mohan, M. S., Salim, S. A., Subhaswaraj, P., & Dyavaiah, M. (2022) · Antibiotics · doi:10.3390/antibiotics11121731 · Cited by 177
Metadata
- Authors
- Han, C., Romero, N., Fischer, S., Dookran, J., Berger, A., & Doiron, A. L.
- Affiliations
- Binghamton University (US)
- Corresponding author
- Doiron, Amber L.
- ORCID
- Doiron, Amber L.
- Venue
- Nanotechnology Reviews
- Publisher
- Walter de Gruyter GmbH
- Published
- 2017-10-26
- Volume
- 6
- Issue
- 5
- Pages
- 383-404
- ISSN
- 2191-9089 (ISSN-L)
- 2191-9097
- OpenAlex
- W2557184343
- Semantic Scholar
- 2168d80c9acb8c364f8c3b161ffa7bc3704bab78
- Cited by
- 114
- References
- 141
- Citations by year
- 2026: 8 · 2025: 20 · 2024: 14 · 2023: 15 · 2022: 14 · 2021: 21 · 2020: 12 · 2019: 6 · 2018: 4
- FWCI
- 1.73
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Nanotechnology Reviews (publishedVersion, cc-by-nc-nd)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bacterial biofilms and quorum sensing
- Physical Sciences › Materials Science › Materials Chemistry › Nanoparticles: synthesis and applications
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Keywords
- nanoparticles, biofilm, biofilm-associated infections, chronic infection, antibiotic resistance, antibiofilm activity, biofilm eradication, nanoparticle characterization, nanotherapeutics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Recent developments in the use of nanoparticles for treatment of biofilms. https://app.cochat.ai/papers/10.1515/ntrev-2016-0054
- The paper
- Han, C., Romero, N., Fischer, S., Dookran, J., Berger, A., & Doiron, A. L. (2017). Recent developments in the use of nanoparticles for treatment of biofilms. Nanotechnology Reviews. https://doi.org/10.1515/ntrev-2016-0054
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.